Dr Patrick Phillips MD regarding Covid-19 Treatment… “Seeing what’s happened with the Ontario Science Table, not recommending Ivermectin, even recommending against Vitamin D, which I think is unthinkable, because the harm is none. This is a natural substance and they’re telling us NOT to give this to these patients despite mortality benefit. I know there is something going wrong and I knew I needed to speak out no matter what the college does to my license.”

Moderate-certainty evidence finds that large reductions in COVID-19 deaths are possible using ivermectin. Using ivermectin early in the clinical course may reduce numbers progressing to severe disease. The apparent safety and low cost suggest that ivermectin is likely to have a significant impact on the SARS-CoV-2 pandemic globally.

In absolute honesty, I don’t think vaccines are even necessary. Why are they not necessary? Well that’s because there are at least four or five safe and effective medicines and their presence has been suppressed and hidden from the public, so they’re not really necessary.

This is pulled straight from the same playbook as the propaganda against HCQ. Even if you’re not sure that one or both of these medicines is effective despite uniformly positive results when applied as early treatment, you should at least recognize the pattern, scratch your head, and question whether there is…maybe…just possibly some perverse incentive like power or profit from vaccines driving this absurdity.

In a letter dated the 23rd of April, 2021, four Guest Editors publicly resigned from the journal Frontiers in Pharmacology. Professor Maria Cristina Albertini, Professor Piero Sestili, Dr. Robert Malone, and Dr. Howard Haimes stepped down in protest over executive decisions not to publish two papers showing positive results of various agents in protecting against or treating COVID-19.

Just as fast as new cases materialized so has the decline thanks in part to a coordinated public health strategy that includes proactive testing, home visits, and medication kits that include ivermectin.

With ivermectin now on the national Indian COVID-19 list of recommended treatments for COVID-19, a few states have gone to the next level and included the low-cost, generic drug approved throughout the world as a parasite fighter as a prophylactic targeting SARS-CoV-2, the virus behind COVID-19.

Zero patients in the ivermectin group that became hospitalized (as compared to 3 in the control group), the results were overall impressive.

Major benefits of ivermectin (IVM) treatment for COVID-19 have been known since the results of 20 such randomized controlled trials (RCTs) were reported

TrialSite hosted the first international Ivermectin for Covid Summit webinar on Sunday, May 23rd 2021. The event was widely attended with medical experts presenting from around the world to a global audience of interested parties in the thousands.

TrialSite hosted the first international Ivermectin for Covid Summit webinar on Sunday, May 23rd 2021. The event was widely attended with medical experts presenting from around the world to a global audience of interested parties in the thousands.

Leading the national trial is Dr. Carolyn Bramante, a U internal medicine specialist. Emphasizing the importance of this trial, she says, “Not everybody has access to the vaccine, whereas these medications are existing generics, already FDA-approved, that are available in most pharmacies around the world.” Dr. Bramante continued, “If we find evidence of benefit, [the drugs] could be used immediately anywhere.”

Dr. Pierre Kory explain both the case that ivermectin (IVM) effectively prevents or treats COVID-19, and also how and why that information is withheld by public health officials.

We are very honored to present this interview of Dr Vladimir Zelenko, the father of outpatient treatment for COVID-19 in North America. Dr Zelenko shares his own experience with COVID-19 as a patient, as he is recovering from a severe form of the disease.
He also talks about his cancer and how he was able to go through this dramatic episode of his life. Then, he presents his perspectives about outpatient treatment as practiced today and the evolution of the pandemic, among other topics.

At this point, continuing the use of Ivermectin has proven safe and we see no reason to stop this drug, which seems to have not only inhibited our second wave but so far prevented a third one.

Today, most leading doctors in India are themselves not promoting the Ministry of Health guidelines that includes the use of hydroxychloroquine, ivermectin and inhaled budesonide.

n a recent interview, Dr. Stone recently shared that while the death rate climbed much higher in January, again peaking at 70 deaths on the 25th of that month, Official authorization for the use of ivermectin was granted a day later.

A month later, the number of deaths fell to zero. Again, the correlation here along with Dr. Stone’s direct clinic experience is ivermectin sales. Over 500,000 doses of the generic, FDA-approved drug were administered from December through February. This compares to 1,057 bottles turned over in January 2020.

If you were going to try and design a drug, for the disease that we call COVID-19, you would want something with heavy anti-viral properties, as well as anti-inflammatory properties.

When you think about that, it’s hard to come up with a better drug for Covid than ivermectin. It literally does both of those things simultaneously, and it’s one of the safest drugs known to man.

The International Ivermectin for Covid Conference​: Dr. Wasif Khan presents his published ivermectin trial and his experience with using ivermectin in Bangladesh.

The International Ivermectin for Covid Conference​: Professor Eli Schwartz shares data and conclusions from his Israeli randomised controlled trial of ivermectin in mild to moderate covid-19.